APA (7th ed.) Citation

Y, S., J, M., W, S., M, J., M, Y., R, N., . . . Y, T. (2019). Infliximab Therapy and the Central Nervous Demyelination in Patients with Kawasaki Disease. The Pediatric infectious disease journal, 38(8), e185. https://doi.org/10.1097/INF.0000000000002296

Chicago Style (17th ed.) Citation

Y, Sagara, et al. "Infliximab Therapy and the Central Nervous Demyelination in Patients with Kawasaki Disease." The Pediatric Infectious Disease Journal 38, no. 8 (2019): e185. https://doi.org/10.1097/INF.0000000000002296.

MLA (9th ed.) Citation

Y, Sagara, et al. "Infliximab Therapy and the Central Nervous Demyelination in Patients with Kawasaki Disease." The Pediatric Infectious Disease Journal, vol. 38, no. 8, 2019, p. e185, https://doi.org/10.1097/INF.0000000000002296.